InMed Pharmaceuticals "announces the Company has entered into a service contract with Brio Financial Group to provide senior financial leadership and bookkeeping services. Pursuant to the Contract, Mr. Jonathan Tegge, a member of Brio, will assume the role of Interim Chief Financial Officer for the Company effective December 12, 2022."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on INM:
- InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
- InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
- InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
- InMed Provides Update on Management Changes
- InMed Pharmaceuticals reports Q1 EPS ($4.06) vs. ($6.17) a year ago